The common shares of Imagin Medical (CSE:IME; OTC:IMEXF) were approved for uplisting from the Pink Open Market to the OTCQB Venture Market, with the same symbol, IMEXF, effective at the open on June 28, 2018.
“Uplisting to OTCQB is an important milestone in our evolution as a public company,” Jim Hutchens, president and CEO, said in a statement.
“We believe this should help with our continuing efforts to broaden our exposure within the investment community, diversify our shareholder base and improve the trading liquidity of our shares,” he added.
